| Authors: |
Bogetz JF; Division of Bioethics and Palliative Care (J.F.B.), Department of Pediatrics, Center for Clinical and Translational Research, Seattle Children's Research Institute, University of Washington School of Medicine, Seattle, Washington, USA. Electronic address: jori.bogetz@seattlechildrens.org., Phan M; Department of Pediatrics (M.P., Y.A.), University of Washington School of Medicine, Seattle, Washington, USA., Ayala E; Treuman Katz Center for Bioethics (E.A.), Center for Clinical and Translational Research, Seattle Children's Research Institute, Seattle, Washington, USA., Alayli Y; Department of Pediatrics (M.P., Y.A.), University of Washington School of Medicine, Seattle, Washington, USA., Johnston EE; Division of Pediatric Hematology-Oncology (E.E.J.), Department of Pediatrics, UAB School of Medicine, Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham School of Medicine, Birmingham, Alabama, USA., Ananth P; Department of Pediatrics (P.A.), Yale Cancer Outcomes, Public Policy and Effectiveness Research (COPPER) Center, Yale School of Medicine, New Haven, Connecticut, USA., McGalliard J; Research Data Application Specialist, Biostatistics (J.M.), Epidemiology and Analytics in Research (BEAR) Core, Seattle Children's Research Institute, Seattle, Washington, USA., Strub B; Senior Research Data Analyst, Biostatistics, Epidemiology and Analytics in Research (BEAR) Core (B.S.), Seattle Children's Research Institute, Seattle, Washington, USA., Bradford MC; Biostatistics, Epidemiology and Analytics in Research (BEAR) Core (M.C.B.), Seattle Children's Research Institute, Seattle, Washington, USA., Rosenberg AR; Department of Supportive Oncology (A.R.S.), Department of Pediatrics, Department of Pediatrics Harvard Medical School, Dana Farber Cancer Institute, Boston Children's Hospital. |